🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cognitive impairment is common in MS and has devastating impact on function...
Status
Completed
Location
Buffalo General Hospital, D3
Start Date
2014-02
Trial ID
NCT02651545
The study is a two-year prospective observational study of patients treated...
Status
Completed
Location
Department of Pathology
Start Date
2016-12-01
Trial ID
NCT03561402
Treatments Being Tested
The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Start Date
2019-01-03
Trial ID
NCT03535298
Treatments Being Tested
Primary Objective: To describe efficacy, tolerability and convenience of t...
Status
Completed
Location
Investigational Site Number 840077
Start Date
2013-06
Trial ID
NCT01895335
Treatments Being Tested
The study is to evaluate the efficacy and safety of evobrutinib administere...
Status
Terminated
Location
Research Site 752
Start Date
2020-07-02
Trial ID
NCT04338061
Treatments Being Tested
This is a Phase 3 extension, global, multicenter study to assess the long-t...
Status
Active Not Recruiting
Location
The University of Alabama at Birmingham- Site Number : 8400013
Start Date
2024-04-16
Trial ID
NCT06372145
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
Primary Objective: To assess efficacy of daily SAR442168 compared to a dai...
Status
Completed
Location
North Central Neurology Associates, PC-Site Number:8400009
Start Date
2020-06-11
Trial ID
NCT04410991
Treatments Being Tested
MAIN STUDY: The purpose of this study is to determine if teriflunomide will...
Status
Completed
Location
Phoenix Neurological Associates, Ltd
Start Date
2013-10
Trial ID
NCT01970410
Treatments Being Tested
The study is to evaluate the efficacy and safety of evobrutinib administere...
Status
Terminated
Location
Research Site 629
Start Date
2020-06-12
Trial ID
NCT04338022
Treatments Being Tested